Bicycle Therapeutics (BCYC) Interest Expenses (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Interest Expenses of $3.6 million for Q1 2026, up 6203.51% on a QoQ basis from $57000.0 in Q4 2025, and up 8.26% year-over-year from $3.3 million in Q1 2025.
Bicycle Therapeutics (BCYC) Interest Expenses (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Interest Expenses history runs 9 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- Quarterly Interest Expenses rose 8.26% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 8.26% YoY) and the FY2025 annual result came in at $126.8 million, up 27.18% from the prior year.
- Interest Expenses was $3.6 million for Q1 2026 at Bicycle Therapeutics, up from $57000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $61.6 million in Q1 2024 and bottomed at $57000.0 in Q4 2025.
- A 5-year average of $19.5 million and a median of $3.6 million in 2026 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses soared 4169.19% — and 2025, when it plunged 95.34%.
- Bicycle Therapeutics' Interest Expenses stood at $275000.0 in 2022, then climbed by 12.73% to $310000.0 in 2023, then jumped by 294.19% to $1.2 million in 2024, then plunged by 95.34% to $57000.0 in 2025, then soared by 6203.51% to $3.6 million in 2026.
- Business Quant data shows BCYC's Interest Expenses at $3.6 million in Q1 2026, $57000.0 in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Bicycle Therapeutics | 272.11 Mn | 272.11 Mn | - | 3.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.59 Mn |
| Mar 31, 2026 | 3.59 Mn |
| Dec 31, 2025 | 57,000.00 |
| Dec 31, 2025 | 57,000.00 |
| Sep 30, 2025 | 3.08 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 43.33 Mn |
| Sep 30, 2024 | 43.33 Mn |
| Jun 30, 2024 | 30.75 Mn |
| Jun 30, 2024 | 30.75 Mn |
| Mar 31, 2024 | 61.56 Mn |
| Mar 31, 2024 | 61.56 Mn |
| Dec 31, 2023 | 310,000.00 |
| Dec 31, 2023 | 310,000.00 |